Clinical trial
A Randomized Double Blind Comparison of Atosiban in Patients With Repeated Implantation Failure Undergoing IVF Treatment
NCT02893722 is registered in ClinicalTrials.gov with Shanghai First Maternity and Infant Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Double Blind Comparison of Atosiban in Patients With Repeated Implantation Failure Undergoing IVF Treatment
- Lead sponsor
- Shanghai First Maternity and Infant Hospital
- Phase
- Phase 1
- Overall status
- Unknown status
- Start date
- January 31, 2017
- Completion date
- December 31, 2018
- Enrollment
- 200 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
repeated implantation failure